iNtRON Biotechnology Inc (048530) — Free Cash Flow Generation Index
iNtRON Biotechnology Inc (048530) has a Free Cash Flow Generation Index of 0.83x as of March 2025. Free cash flow of ₩1.62 Billion represents 1% of operating cash flow (₩1.94 Billion). Explore iNtRON Biotechnology Inc (048530) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
iNtRON Biotechnology Inc Free Cash Flow Generation Index (2015–2023)
Historical FCF Generation Index trend for iNtRON Biotechnology Inc across 6 annual periods. For the full cash flow conversion analysis, see 048530 cash generation efficiency.
Annual Free Cash Flow Generation for iNtRON Biotechnology Inc (2015–2023)
Year-by-year Free Cash Flow Generation Index for iNtRON Biotechnology Inc. Check iNtRON Biotechnology Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | -2.06x | ₩-6.43 Billion | ₩3.12 Billion | ₩9.55 Billion | ▼ -467.1% |
| 2022 | 0.56x | ₩3.36 Billion | ₩5.98 Billion | ₩2.23 Billion | ▼ -28.6% |
| 2021 | 0.79x | ₩12.98 Billion | ₩16.47 Billion | ₩3.05 Billion | ▲ +429.7% |
| 2020 | 0.15x | ₩1.06 Billion | ₩7.13 Billion | ₩4.85 Billion | ▼ -86.9% |
| 2018 | 1.13x | ₩4.75 Billion | ₩4.20 Billion | ₩550.58 Million | ▼ -76.0% |
| 2015 | 4.71x | ₩8.00 Billion | ₩1.70 Billion | ₩6.30 Billion | — |